898 filings
Page 27 of 45
8-K
ixrb7yp5
1 Nov 12
Other Events
12:00am
8-K
cqsh5
15 Oct 12
Delcath Announces Fda Accepts New Drug Application for Its
12:00am
EFFECT
cz7y65 d84ev0
9 Oct 12
Notice of effectiveness
12:00am
CORRESP
s726bojbkxb8fwxwksck
4 Oct 12
Correspondence with SEC
12:00am
CORRESP
aaufej2dhgmtlg2
27 Sep 12
Correspondence with SEC
12:00am
UPLOAD
baag6f7ss wcjmlroo
14 Sep 12
Letter from SEC
12:00am
8-K
k20k 0w3vqfj7
16 Aug 12
Delcath Submits New Drug Application for Proprietary Chemosaturation System to the U.s. Food and Drug Administration
12:00am
8-K
hrtyoxy8bzjsp
14 Aug 12
This presentation contains forward-looking statements within the meaning of the Safe Harbor Provisions of the U.S. Private Securities
12:00am
8-K
6j0gak4r 4s
13 Aug 12
Second Quarter 2012 Corporate Update Call
12:00am
8-K
08zskcj
7 Aug 12
Delcath Reports Second Quarter 2012 Financial Results and Highlights
12:00am
8-K
76fych 0wqhfmu44
19 Jul 12
Departure of Directors or Certain Officers
12:00am
8-K
6uxxdtz4 b7zkjw0g
9 Jul 12
Delcath Announced Changes to Board of Directors
12:00am
S-8
mfwlc1rxntc 6kd4nj
8 Jun 12
Registration of securities for employees
12:00am
8-K
bf2i3apl x3y2t
31 May 12
Delcath Announces Exercise of Underwriters’ Over-Allotment option and Closing of $23 million
12:00am
8-K
5cij3
30 May 12
Material Modifications to Rights of Security Holders
12:00am
424B5
ty6ur
25 May 12
Prospectus supplement for primary offering
12:00am
424B5
vb5ge0900o34
24 May 12
Prospectus supplement for primary offering
12:00am